Fact CheckerSign in

NCT05067231Recruiting

CARBON: UAB Cardiovascular Research Biobank

UAB Cardiovascular Research Biobank

Source: ClinicalTrials.gov · Last updated 13 Feb 2026

Brief summary (registry, in English)

The UAB Cardiovascular Research Biobank (CARBON) will be a resource that contains biological materials, such as DNA samples, in addition to health and personal information on a large number of people over time. It will be set up so that it can be used in the future as a resource for researchers undertaking a wide range of medical research.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
23 Sept 2021
Start date
1 Jan 2022
Primary completion date
1 Jan 2030
Lead sponsor
University of Alabama at Birmingham
NCT number
NCT05067231

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 1 Jan 2022 to the primary completion date, 1 Jan 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Employees or students associated with the Division of Cardiovascular Disease at UAB will not be recruited due to their vulnerable status and susceptibility to coercion.

Age

  • Age \<18, at screening

Other

  • Women who are pregnant or who can become pregnant and not practicing an acceptable method of birth control.

Who the study is looking for

  • Age more than or equal to 18

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Alabama at Birmingham
Coordinator of this site? Confirm its status
BirminghamUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.